HealthNotableConfirmed
5.9
FDA approves Roche and Eli Lilly Alzheimer's blood diagnostic test
Valor Econômico·US·3 days ago
Scientists at Conicet have identified molecular markers that allow for the prediction of severe complications in a condition affecting 30% of adults. The breakthrough enables personalized treatment protocols, though the specific disease name was not disclosed in the initial report.
Locations
Entities